MedTech firm Cerus Endovascular has been acquired  in a deal that that provides a 15x return for its North West investor. Cerus, whose products – Contour and Neqstent – have been successful in treating brain aneurysms which can lead to strokes and even death, has previously  been backed by the North West Fund. The company’s … Continue reading North West investor bags 15x return after MedTech sale